Cargando…

Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study

OBJECTIVE: Although interleukin-1 receptor antagonist (IL-1Ra) treatment is associated with improved β-cell function and glycemic control in patients with type 2 diabetes, its role in the development of type 2 diabetes remains unclear. We used repeated measurements to characterize IL-1Ra trajectorie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carstensen, Maren, Herder, Christian, Kivimäki, Mika, Jokela, Markus, Roden, Michael, Shipley, Martin J., Witte, Daniel R., Brunner, Eric J., Tabák, Adam G.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857902/ https://www.ncbi.nlm.nih.gov/pubmed/20185814 http://dx.doi.org/10.2337/db09-1199

Ejemplares similares

Adiponectin Trajectories Before Type 2 Diabetes Diagnosis: Whitehall II study
por: Tabák, Adam G., et al.
Publicado: (2012)

Patterns of Obesity Development before the Diagnosis of Type 2 Diabetes: The Whitehall II Cohort Study
por: Vistisen, Dorte, et al.
Publicado: (2014)

Determinants of Aortic Stiffness: 16-Year Follow-Up of the Whitehall II Study
por: Johansen, Nanna B., et al.
Publicado: (2012)

Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study
por: Hansen, Christian Stevns, et al.
Publicado: (2017)

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study
por: Herder, Christian, et al.
Publicado: (2009)

Hyperglycemia, Type 2 Diabetes, and Depressive Symptoms: The British Whitehall II study
por: Kivimaki, Mika, et al.
Publicado: (2009)

Nondiabetic Glucometabolic Status and Progression of Aortic Stiffness: The Whitehall II Study
por: McEniery, Carmel M., et al.
Publicado: (2017)

Metabolic Syndrome Over 10 Years and Cognitive Functioning in Late Midlife: The Whitehall II study
por: Akbaraly, Tasnime N., et al.
Publicado: (2010)

Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study
por: Bouillon, Kim, et al.
Publicado: (2011)

Overall Diet History and Reversibility of the Metabolic Syndrome Over 5 Years: The Whitehall II prospective cohort study
por: Akbaraly, Tasnime N., et al.
Publicado: (2010)

Dietary pattern, inflammation and cognitive decline: The Whitehall II prospective cohort study
por: Ozawa, Mio, et al.
Publicado: (2017)

Physical Activity, Sedentary Behavior, and Long‐Term Changes in Aortic Stiffness: The Whitehall II Study
por: Ahmadi‐Abhari, Sara, et al.
Publicado: (2017)

Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study
por: Vistisen, Dorte, et al.
Publicado: (2019)

Effect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985–2009
por: Hulmán, Adam, et al.
Publicado: (2014)

Adiposity, Obesity, and Arterial Aging: Longitudinal Study of Aortic Stiffness in the Whitehall II Cohort
por: Brunner, Eric J., et al.
Publicado: (2015)

Change in Sleep Duration and Type 2 Diabetes: The Whitehall II Study
por: Ferrie, Jane E., et al.
Publicado: (2015)

Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study
por: Hulman, Adam, et al.
Publicado: (2017)

Validating a widely used measure of frailty: are all sub-components necessary? Evidence from the Whitehall II cohort study
por: Bouillon, Kim, et al.
Publicado: (2012)

Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study
por: Tabák, Adam G., et al.
Publicado: (2022)

Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study
por: Singh-Manoux, Archana, et al.
Publicado: (2018)

Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study
por: Stringhini, Silvia, et al.
Publicado: (2012)

Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study
por: Elbaz, Alexis, et al.
Publicado: (2012)

Socioeconomic Differences in Cardiometabolic Factors: Social Causation or Health-related Selection? Evidence From the Whitehall II Cohort Study, 1991–2004
por: Elovainio, Marko, et al.
Publicado: (2011)

Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: The Whitehall II study()()
por: Elbaz, Alexis, et al.
Publicado: (2014)

Diabetes Risk Factors, Diabetes Risk Algorithms, and the Prediction of Future Frailty: The Whitehall II Prospective Cohort Study
por: Bouillon, Kim, et al.
Publicado: (2013)

Association of Lifecourse Socioeconomic Status with Chronic Inflammation and Type 2 Diabetes Risk: The Whitehall II Prospective Cohort Study
por: Stringhini, Silvia, et al.
Publicado: (2013)

Genetic Determinants of Circulating Interleukin-1 Receptor Antagonist Levels and Their Association With Glycemic Traits
por: Herder, Christian, et al.
Publicado: (2014)

Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study
por: Hansen, Christian S., et al.
Publicado: (2021)

Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study
por: Kivimäki, Mika, et al.
Publicado: (2009)

Association of aortic stiffness with cognitive decline: Whitehall II longitudinal cohort study
por: Araghi, Marzieh, et al.
Publicado: (2019)

Association of attrition with mortality: Findings from 11 waves over three decades of the Whitehall II study
por: Akasaki, Mifuyu, et al.
Publicado: (2020)

Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension
por: Abell, Jessica G, et al.
Publicado: (2018)

Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study
por: Ikehara, Satoyo, et al.
Publicado: (2014)

Underweight as a risk factor for respiratory death in the Whitehall cohort study: exploring reverse causality using a 45-year follow-up
por: Kivimäki, Mika, et al.
Publicado: (2016)

Associations of Common Genetic Variants With Age-Related Changes in Fasting and Postload Glucose: Evidence From 18 Years of Follow-Up of the Whitehall II Cohort
por: Jensen, Anders C., et al.
Publicado: (2011)

Long-term Adherence to Healthy Dietary Guidelines and Chronic Inflammation in the Prospective Whitehall II Study()
por: Akbaraly, Tasnime N., et al.
Publicado: (2015)

Assessing cortisol from hair samples in a large observational cohort: The Whitehall II study
por: Abell, Jessica G., et al.
Publicado: (2016)

Recurrent short sleep, chronic insomnia symptoms and salivary cortisol: A 10-year follow-up in the Whitehall II study
por: Abell, Jessica G., et al.
Publicado: (2016)

Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study
por: Lindbohm, Joni V, et al.
Publicado: (2021)

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study
por: Tuligenga, Richard H, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_55be161a90f17hobiou0cjgm5r